Handelsbanken Fonder Ab Sarepta Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 23,815 shares of SRPT stock, worth $2.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,815

Previous 21,215 12.26%

Holding current value

$2.99 Million

Previous $3.35 Million 11.28%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$124.33 - $156.75 $323,258 - $407,550	2,600 Added 12.26%	23,815 $2.97 Million
Q2 2024 Aug 05, 2024	BUY	$113.33 - $163.85 $328,657 - $475,165	2,900 Added 15.83%	21,215 $3.35 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $140,550 - $212,295	1,500 Added 8.92%	18,315 $2.37 Million
Q4 2023 Feb 01, 2024	BUY	$67.31 - $124.76 $60,579 - $112,284	900 Added 5.66%	16,815 $1.62 Million
Q3 2023 Oct 19, 2023	BUY	$102.5 - $123.59 $206,332 - $248,786	2,013 Added 14.48%	15,915 $1.93 Million
Q2 2023 Aug 02, 2023	BUY	$106.4 - $157.19 $95,760 - $141,471	900 Added 6.92%	13,902 $1.59 Million
Q1 2023 Apr 28, 2023	BUY	$117.53 - $155.99 $164,542 - $218,386	1,400 Added 12.07%	13,002 $1.79 Million
Q2 2022 Aug 03, 2022	SELL	$62.69 - $88.44 $94,035 - $132,660	-1,500 Reduced 11.45%	11,602 $870,000
Q2 2021 Aug 03, 2021	SELL	$69.38 - $86.75 $111,008 - $138,800	-1,600 Reduced 10.88%	13,102 $1.02 Million
Q1 2021 Apr 29, 2021	SELL	$72.25 - $168.95 $2.85 Million - $6.67 Million	-39,500 Reduced 72.88%	14,702 $1.1 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $2.11 Million - $3.9 Million	22,702 Added 72.07%	54,202 $8.69 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $823,800 - $1.32 Million	10,000 Added 46.51%	31,500 $3.08 Million
Q2 2019 Jul 12, 2019	SELL	$112.21 - $151.95 $561,050 - $759,750	-5,000 Reduced 18.87%	21,500 $3.27 Million
Q4 2018 Jan 31, 2019	SELL	$97.32 - $148.76 $583,920 - $892,560	-6,000 Reduced 18.46%	26,500 $2.89 Million
Q3 2018 Oct 23, 2018	BUY	$115.31 - $161.51 $3.75 Million - $5.25 Million	32,500 New	32,500 $5.25 Million
Q3 2018 Oct 19, 2018	SELL	$115.31 - $161.51 $3.4 Million - $4.76 Million	-29,500 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$71.74 - $153.69 $286,960 - $614,760	-4,000 Reduced 11.94%	29,500 $3.9 Million
Q1 2018 May 18, 2018	BUY	$54.02 - $82.27 $648,240 - $987,240	12,000 Added 55.81%	33,500 $2.48 Million
Q4 2017 Feb 08, 2018	BUY	$47.64 - $56.75 $1.02 Million - $1.22 Million	21,500	21,500 $1.2 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Sarepta Therapeutics, Inc. Transaction History